ID

15130

Beschrijving

Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02330406

Link

https://clinicaltrials.gov/show/NCT02330406

Trefwoorden

Versies (1)
  1. 17-05-16 17-05-16 -
Geüploaded op

17 mei 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Dipeptidyl-Peptidase 4 Inhibitors NCT02330406

Engels

Eligibility Dipeptidyl-Peptidase 4 Inhibitors NCT02330406

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with type 2 diabetes with coronary heart diseases who treated with diet, exercise or antidiabetic medications
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent | Coronary heart disease | Diet therapy | Treated with Exercise | Treated with Antidiabetics

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2]
C0010068
UMLS CUI [3]
C0012159
UMLS CUI [4,1]
C0332293
UMLS CUI [4,2]
C0015259
UMLS CUI [5,1]
C0332293
UMLS CUI [5,2]
C0935929
patients who were treated with statins for 8 weeks or longer
Beschrijving

Treated with Hydroxymethylglutaryl-CoA Reductase Inhibitors

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332293
UMLS CUI [1,2]
C0360714
patients with low-density lipoprotein cholesterol equal to or greater than 100 mg/dl in the at least two of three measurements after the administration of statins
Beschrijving

Low density lipoprotein cholesterol measurement Post Administration Hydroxymethylglutaryl-CoA Reductase Inhibitors

Datatype

boolean

Alias
UMLS CUI [1,1]
C0202117
UMLS CUI [1,2]
C0687676
UMLS CUI [1,3]
C1533734
UMLS CUI [1,4]
C0360714
patients with glycerated hemoglobin (hba1c, ngsp) equal to or greater than 6.0 % (7.0
Beschrijving

hemoglobin, glycerated | Glycosylated hemoglobin A

Datatype

boolean

Alias
UMLS CUI [1]
C0062477
UMLS CUI [2]
C0019018
% if patients were not treated with dipeptidyl-peptidase 4 inhibitors) and lesser than 10.5 %
Beschrijving

Treated with Dipeptidyl-Peptidase IV Inhibitors

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332293
UMLS CUI [1,2]
C1827106
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with type 1 diabetes
Beschrijving

Diabetes Mellitus, Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011854
patients with triglyceride equal to or greater than 400 mg/dl in the previous fasting measuments
Beschrijving

Triglycerides measurement Fasting

Datatype

boolean

Alias
UMLS CUI [1,1]
C0202236
UMLS CUI [1,2]
C0015663
patients who were received insulin therapy or considered to need insulin therapy
Beschrijving

Insulin therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0557978
patients with pregnancy, possible pregnancy, or on breast-feeding
Beschrijving

Pregnancy | Possible Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0332149
UMLS CUI [2,2]
C0032961
UMLS CUI [3]
C0006147
patients with severe infections, perioperative status, or severe trauma
Beschrijving

Infection Severe | Status perioperative | Trauma Severe

Datatype

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0449438
UMLS CUI [2,2]
C1518988
UMLS CUI [3,1]
C3714660
UMLS CUI [3,2]
C0205082
patients who were received glucagon-like peptide-1receptor agonists, rapid insulin secretagogue, or sodium glucose cotransporter 2 inhibitor
Beschrijving

Glucagon-Like Peptide-1 Receptor agonists | Insulin, Rapid-Acting | Sodium-Glucose Cotransporter 2 Inhibitor

Datatype

boolean

Alias
UMLS CUI [1,1]
C0378073
UMLS CUI [1,2]
C0243192
UMLS CUI [2]
C0356365
UMLS CUI [3]
C3542461
patients whom physician in charge considered inappropriate for the study
Beschrijving

Patient Inappropriate Clinical Trial

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C0008976
Terug naar het begin van de pagina

Similar models

Eligibility Dipeptidyl-Peptidase 4 Inhibitors NCT02330406

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent | Coronary heart disease | Diet therapy | Treated with Exercise | Treated with Antidiabetics
Item
patients with type 2 diabetes with coronary heart diseases who treated with diet, exercise or antidiabetic medications
boolean
C0011860 (UMLS CUI [1])
C0010068 (UMLS CUI [2])
C0012159 (UMLS CUI [3])
C0332293 (UMLS CUI [4,1])
C0015259 (UMLS CUI [4,2])
C0332293 (UMLS CUI [5,1])
C0935929 (UMLS CUI [5,2])
Treated with Hydroxymethylglutaryl-CoA Reductase Inhibitors
Item
patients who were treated with statins for 8 weeks or longer
boolean
C0332293 (UMLS CUI [1,1])
C0360714 (UMLS CUI [1,2])
Low density lipoprotein cholesterol measurement Post Administration Hydroxymethylglutaryl-CoA Reductase Inhibitors
Item
patients with low-density lipoprotein cholesterol equal to or greater than 100 mg/dl in the at least two of three measurements after the administration of statins
boolean
C0202117 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
C1533734 (UMLS CUI [1,3])
C0360714 (UMLS CUI [1,4])
hemoglobin, glycerated | Glycosylated hemoglobin A
Item
patients with glycerated hemoglobin (hba1c, ngsp) equal to or greater than 6.0 % (7.0
boolean
C0062477 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
Treated with Dipeptidyl-Peptidase IV Inhibitors
Item
% if patients were not treated with dipeptidyl-peptidase 4 inhibitors) and lesser than 10.5 %
boolean
C0332293 (UMLS CUI [1,1])
C1827106 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
patients with type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Triglycerides measurement Fasting
Item
patients with triglyceride equal to or greater than 400 mg/dl in the previous fasting measuments
boolean
C0202236 (UMLS CUI [1,1])
C0015663 (UMLS CUI [1,2])
Insulin therapy
Item
patients who were received insulin therapy or considered to need insulin therapy
boolean
C0557978 (UMLS CUI [1])
Pregnancy | Possible Pregnancy | Breast Feeding
Item
patients with pregnancy, possible pregnancy, or on breast-feeding
boolean
C0032961 (UMLS CUI [1])
C0332149 (UMLS CUI [2,1])
C0032961 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3])
Infection Severe | Status perioperative | Trauma Severe
Item
patients with severe infections, perioperative status, or severe trauma
boolean
C3714514 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0449438 (UMLS CUI [2,1])
C1518988 (UMLS CUI [2,2])
C3714660 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Glucagon-Like Peptide-1 Receptor agonists | Insulin, Rapid-Acting | Sodium-Glucose Cotransporter 2 Inhibitor
Item
patients who were received glucagon-like peptide-1receptor agonists, rapid insulin secretagogue, or sodium glucose cotransporter 2 inhibitor
boolean
C0378073 (UMLS CUI [1,1])
C0243192 (UMLS CUI [1,2])
C0356365 (UMLS CUI [2])
C3542461 (UMLS CUI [3])
Patient Inappropriate Clinical Trial
Item
patients whom physician in charge considered inappropriate for the study
boolean
C0030705 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial